NCT05927597View on ClinicalTrials.gov

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

INS1007

Oral tablets.

DRUG

Placebo

Oral tablets.

Trial Locations (1)

91206

USA001, Glendale

All Listed Sponsors
lead

Insmed Incorporated

INDUSTRY

NCT05927597 - A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants | Biotech Hunter | Biotech Hunter